Industry Educational Session - Challenging the Standard of Care post 2 TKIs for patients with Ph+ CP-CML: Real World Experience - Sponsored by Novartis
Tracks
Track 3
| Tuesday, April 30, 2024 |
| 12:20 PM - 1:05 PM |
| Room 3A |
Details
In this symposium, Professor Dragana Milojkovic, Professor Mhari Copland and Dr Nauman Butt will discuss the challenges of treating Ph+ CP-CML patients following 2 TKIs whilst sharing their experience of treating complex patients and those not achieving their treatment milestones, whilst also discussing the changing tide on the standard of care in the post 2 TKI setting.
This is a promotional symposium organised and funded by Novartis Pharmaceuticals UK Limited. It is intended for UK healthcare professionals only. Prescribing information will be available at the symposium. For more information, speak to a member of the Novartis team on Stand 17. March 2024 420038.
Speaker
Dr Dragana Milojkovic
Consultant Haematologist
Imperial College Healthcare Nhs Trust, London, Uk
-
